Zobrazeno 1 - 6
of 6
pro vyhledávání: '"Nada Bejar"'
Autor:
Elisabeth Laville, Josette Perrier, Nada Bejar, Marc Maresca, Jeremy Esque, Alexandra S. Tauzin, Emna Bouhajja, Marion Leclerc, Elodie Drula, Bernard Henrissat, Stephane Berdah, Eric Di Pasquale, Patrick Robe, Gabrielle Potocki-Veronese
Publikováno v:
Frontiers in Microbiology, Vol 10 (2019)
The human Intestinal mucus is formed by glycoproteins, the O- and N-linked glycans which constitute a crucial source of carbon for commensal gut bacteria, especially when deprived of dietary glycans of plant origin. In recent years, a dozen carbohydr
Externí odkaz:
https://doaj.org/article/ad4a9dcce15f4ef1b98584e3b8b87cff
Publikováno v:
Journal of Dermatology and Skin Science. 5:4-13
Despite being under development for decades, RNA therapeutics have only recently emerged as viable drug platforms. The COVID-19 mRNA vaccines have demonstrated the promise and power of the platform technology. In response, novel RNA drugs are enterin
Despite being under development for decades, RNA therapeutics have only recently emerged as viable platform technologies. The COVID-19 mRNA vaccines have demonstrated the promise and power of the platform technology. In response, novel RNA drugs are
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::06f351d5aa518406630f2b9a1a123137
Autor:
Yao Yu, Rolando Alvarado, Lauren E Petty, Ryan J Bohlender, Douglas M Shaw, Jennifer E Below, Nada Bejar, Oscar E Ruiz, Bhavna Tandon, George T Eisenhoffer, Daniel L Kiss, Chad D Huff, Ariadne Letra, Jacqueline T Hecht
Publikováno v:
Hum Mol Genet
Non-syndromic cleft lip with or without cleft palate (NSCL/P) is a common, severe craniofacial malformation that imposes significant medical, psychosocial and financial burdens. NSCL/P is a multifactorial disorder with genetic and environmental facto
Purpose of review: RNA therapeutics are a new and rapidly expanding class of drugs to prevent or treat a wide spectrum of diseases. We discuss the defining characteristics of the diverse family of molecules under the RNA therapeutics umbrella. Recent
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::dcf8b24daef4cbd9ab7315304b9b0735
https://doi.org/10.20944/preprints202112.0273.v1
https://doi.org/10.20944/preprints202112.0273.v1
Autor:
Elisabeth Laville, Josette Perrier, Nada Bejar, Marc Maresca, Jeremy Esque, Alexandra S. Tauzin, Emna Bouhajja, Marion Leclerc, Elodie Drula, Bernard Henrissat, Stephane Berdah, Eric Di Pasquale, Patrick Robe, Gabrielle Potocki-Veronese
Publikováno v:
Frontiers in Microbiology
Frontiers in Microbiology, Frontiers Media, 2019, 10, 12 p. ⟨10.3389/fmicb.2019.01286⟩
Frontiers in Microbiology, 2019, 10, 12 p. ⟨10.3389/fmicb.2019.01286⟩
Frontiers in Microbiology, Vol 10 (2019)
Frontiers in Microbiology (10), 12 p.. (2019)
Frontiers in Microbiology, Frontiers Media, 2019, 10, 12 p. ⟨10.3389/fmicb.2019.01286⟩
Frontiers in Microbiology, 2019, 10, 12 p. ⟨10.3389/fmicb.2019.01286⟩
Frontiers in Microbiology, Vol 10 (2019)
Frontiers in Microbiology (10), 12 p.. (2019)
The human Intestinal mucus is formed by glycoproteins, the O- and N-linked glycans which constitute a crucial source of carbon for commensal gut bacteria, especially when deprived of dietary glycans of plant origin. In recent years, a dozen carbohydr